Shames Richard S.

CIK 00016758781 companyMILPITAS, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001675878

Recent Transactions

20 trades

Sale
Protagonist Therapeutics, Inc$PTGX
Common Stock
2019-03-01$8.03/sh−657→ 32,021 total
Award
Protagonist Therapeutics, Inc$PTGX
Common Stock
2019-02-28+8,500→ 32,678 total
Award
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2019-02-28+51,000→ 51,000 total
Sale
Protagonist Therapeutics, Inc$PTGX
Common Stock
2019-02-06$8.15/sh−198→ 26,758 total
Sale
Protagonist Therapeutics, Inc$PTGX
Common Stock
2019-02-06$7.71/sh−2,580→ 24,178 total
Award
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2018-08-15+12,500→ 12,500 total
Award
Protagonist Therapeutics, Inc$PTGX
Common Stock
2018-08-15+18,750→ 26,956 total
Award
Protagonist Therapeutics, Inc$PTGX
Common Stock
2018-02-28+6,500→ 6,500 total
Award
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2018-02-28+37,500→ 37,500 total
Exercise/Conversion
Protagonist Therapeutics, Inc$PTGX
Common Stock
2017-12-22$4.21/sh+3,529→ 3,529 total
Sale
Protagonist Therapeutics, Inc$PTGX
Common Stock
2017-12-22$20.50/sh−3,529→ 0 total
Exercise/Conversion
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2017-12-22−3,529→ 33,273 total
Exercise/Conversion
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2017-10-05−2,017→ 36,802 total
Exercise/Conversion
Protagonist Therapeutics, Inc$PTGX
Common Stock
2017-10-05$4.21/sh+2,017→ 2,017 total
Sale
Protagonist Therapeutics, Inc$PTGX
Common Stock
2017-10-05$19.00/sh−2,017→ 0 total
Sale
Protagonist Therapeutics, Inc$PTGX
Common Stock
2017-09-12$14.31/sh−3,687→ 0 total
Exercise/Conversion
Protagonist Therapeutics, Inc$PTGX
Common Stock
2017-08-29$4.21/sh+1,512→ 3,377 total
Sale
Protagonist Therapeutics, Inc$PTGX
Common Stock
2017-08-29$17.00/sh−1,512→ 1,865 total
Exercise/Conversion
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2017-08-29−1,512→ 38,819 total
Award
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2016-10-11+65,000→ 65,000 total

Companies

Protagonist Therapeutics, Inc
Chief Medical Officer
$PTGX

Recent Filings

Address

C/O PROTAGONIST THERAPEUTICS, INC. 521 COTTONWOOD DRIVE, SUITE 100

MILPITAS, CA, 95035

View on SEC.gov